Nautilus Biotechnology (NAUT) Non Operating Income (2020 - 2026)

Nautilus Biotechnology (NAUT) has 7 years of Non Operating Income data on file, last reported at $1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income fell 35.37% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $7.1 million (down 30.12% YoY), and the FY2025 full-year result was $7.9 million, down 27.01% from the prior year.
• Non Operating Income declined to $1.4 million in Q1 2026, from $1.7 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $3.2 million in Q2 2023 to a low of $259000.0 in Q1 2022.
• A 5-year average of $2.3 million and a median of $2.5 million in 2024 frame the typical range for Non Operating Income.
• Across the five-year window, Non Operating Income surged 4950.0% in 2022 and plunged 35.37% in 2026, its largest moves.
• Tracing NAUT's Non Operating Income over 5 years: stood at $2.9 million in 2022, then rose by 2.83% to $3.0 million in 2023, then slipped by 17.03% to $2.5 million in 2024, then sank by 32.19% to $1.7 million in 2025, then declined by 13.91% to $1.4 million in 2026.
• Business Quant data shows NAUT's Non Operating Income at $1.4 million in Q1 2026, $1.7 million in Q4 2025, and $1.9 million in Q3 2025.